Trial intelligence / Profile preview

Intraperitoneal bupivacaine vs saline plus pulmonary recruitment maneuver for post-laparoscopic shoulder pain

IRCT20190113042346N2Phase 2Completed

Sponsor
North Khorasan University of Medical Sciences
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of bupivacaine in shoulder pain (2 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoint: Post-laparoscopic shoulder pain intensity. Started Jan 2021; status: completed.

02

Drugs

bupivacaine
03

Conditions

shoulder pain

Beyond the preview

Go deeper on IRCT20190113042346N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190113042346N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call